Trials / Completed
CompletedNCT03344107
Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents
Comparison Between Symptoms Related to Polaris Loop Stent Versus Vortek Double J Stent After Uncomplicated Flexible Ureterorenoscopy for Renal Stones
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- A.O.U. Città della Salute e della Scienza · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective randomized controlled single-blind parallel-group trial in order to compare symptoms related to loop-tail (Polaris Loop) stents versus conventional double J (Vortek) stents after uncomplicated flexible URS.
Detailed description
Patients undergoing RIRS for a single renal stone \< 2 cm are asked to participate in a prospective randomized controlled single-blind parallel-group study. Ureteral stent is always placed after flexible URS. Patients are prospectively randomized into two groups with a 1:1 allocation: group LT receive loop-tail stents (Polaris ™ Loop - Boston Scientific, Natick, USA), while group DJ receive conventional double J stents (Vortek ® - Coloplast, Humlebaek, DK). Stent removal is planned 4 weeks after the procedure. Participants are asked to fill in the Italian validated version of the Ureteral Stent Symptoms Questionnaire (USSQ) 2 days and 4 weeks after surgery. The USSQ is further submitted 4 weeks after stent removal (8 weeks after surgery) and these results are used as baseline evaluation, on the assumption that SRS persist for a few days after removal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | USSQ questionnaire administration after RIRS. | USSQ symptoms questionnaire administration after RIRS |
Timeline
- Start date
- 2018-01-10
- Primary completion
- 2020-02-13
- Completion
- 2020-04-17
- First posted
- 2017-11-17
- Last updated
- 2020-12-01
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03344107. Inclusion in this directory is not an endorsement.